middle.news
How Is Recce Pharmaceuticals Navigating Rising Losses Amid Clinical Breakthroughs?
8:02pm on Friday 27th of February, 2026 AEDT
•
Healthcare
Read Story
How Is Recce Pharmaceuticals Navigating Rising Losses Amid Clinical Breakthroughs?
8:02pm on Friday 27th of February, 2026 AEDT
Key Points
Net loss more than doubled to $16.56 million in H1 2026
Positive preclinical and clinical data on RECCE® 327 against antibiotic-resistant pathogens
Phase 3 clinical trial underway in Indonesia targeting diabetic foot infections
Hong Kong patent granted extending protection to 2041
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
RECCE PHARMACEUTICALS (ASX:RCE)
OPEN ARTICLE